How were FDA investigators first alerted to problems related to nonclinical laboratory study conduct?
A. Inconsistent and or unexplained entries in data submitted to the FDA
B. Technical report writers reported the issues because they were concerned about animal abuse
C. "Whistleblowers" reported the issues because they were concerned with their own safety
D. Complaints to the EPA about unforeseen drug reactions from the use of prescription medications
